Evaluation of Response Criteria in Rheumatoid Arthritis Treated With Biologic Disease-Modifying Antirheumatic Drugs.
Mariko InoueHiroko KandaShoko TateishiKeishi FujioPublished in: Arthritis care & research (2020)
EULAR response criteria overestimate the response under IL-6i treatment because the APR improvement largely contributes to the DAS28 improvement.